Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amplia Therapeutics Ltd. (AU:ATX)
ASX:ATX
Holding AU:ATX?
Track your performance easily
ATX Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.05 - AU$0.18
Previous CloseAU$0.08
Volume357.18K
Average Volume (3M)1.24M
Market Cap
AU$32.20M
Enterprise ValueAU$19.69M
Total Cash (Recent Filing)AU$14.61M
Total Debt (Recent Filing)AU$2.10M
Price to Earnings (P/E)―
Beta0.03
Next Earnings
Jun 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares OutstandingN/A
10 Day Avg. Volume1,249,186
30 Day Avg. Volume1,236,719
Standard Deviation0.19
R-Squared0.10
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Amplia Therapeutics Ltd. News
PremiumCompany Announcements
Amplia Therapeutics Secures $13 Million in Capital Raise
PremiumCompany Announcements
Amplia Therapeutics Announces Director’s Increased Shareholding
PremiumCompany Announcements
Amplia Therapeutics Announces Director’s Share Acquisition
PremiumCompany Announcements
Amplia Therapeutics Announces Change in Director’s Interest
PremiumCompany Announcements
Amplia Therapeutics Director Increases Stake, Boosting Investor InterestPremiumCompany Announcements
Amplia Therapeutics Lists New Securities on ASXPremiumCompany Announcements
Amplia Therapeutics Issues New Equity Options
PremiumCompany Announcements
Amplia Therapeutics Shows Promising Data in Cancer TrialOptions Prices
Currently, No data available
---
Ownership Overview
ATX FAQ
What was Amplia Therapeutics Ltd.’s price range in the past 12 months?
Amplia Therapeutics Ltd. lowest share price was AU$0.05 and its highest was AU$0.17 in the past 12 months.
What is Amplia Therapeutics Ltd.’s market cap?
Currently, no data Available
When is Amplia Therapeutics Ltd.’s upcoming earnings report date?
Amplia Therapeutics Ltd.’s upcoming earnings report date is Jun 02, 2025 which is in 162 days.
How were Amplia Therapeutics Ltd.’s earnings last quarter?
Currently, no data Available
Is Amplia Therapeutics Ltd. overvalued?
According to Wall Street analysts Amplia Therapeutics Ltd.’s price is currently Overvalued.
Does Amplia Therapeutics Ltd. pay dividends?
Amplia Therapeutics Ltd. does not currently pay dividends.
What is Amplia Therapeutics Ltd.’s EPS estimate?
Amplia Therapeutics Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Amplia Therapeutics Ltd. have?
Amplia Therapeutics Ltd. has 387,952,670 shares outstanding.
What happened to Amplia Therapeutics Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Amplia Therapeutics Ltd.?
Currently, no hedge funds are holding shares in AU:ATX
---
Amplia Therapeutics Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:ATX Sentiment 96%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $203.2K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
160.86%
12-Months-Change
Fundamentals
Return on Equity
-32.71%
Trailing 12-Months
Asset Growth
-22.61%
Trailing 12-Months
Company Description
Amplia Therapeutics Ltd.
Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.
---
Technical Analysis
Anixa Biosciences
―
Immutep
―
Cellectar Biosciences
―
TG Therapeutics
―
Amplia Therapeutics Ltd.
―
---